|Day's Range||2.50 - 2.70|
|52 Week Range||1.40 - 13.80|
|PE Ratio (TTM)||-0.28|
|Earnings Date||Jul 26, 2017 - Aug 2, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||24.00|
Canadian Patent Allowance Expands Coverage for RosettaGX Reveal™ Thyroid MicroRNA Classifier PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / July 6, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic ...
Categories: Yahoo FinanceGet free summary analysis Rosetta Genomics Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Rosetta Genomics Ltd. – Veracyte Inc, Foundation Medicine, Inc., Trovagene, Inc., Genomic Health, Inc., Exact Sciences Corporation, Teva Pharmaceutical Industries Limited Sponsored ADR, Biocept, Inc. and GeneNews Limited ... Read more (Read more...)
PHILADELPHIA, PA AND REHOVOT, ISRAEL / ACCESSWIRE / May 25, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate ...